LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,089
تعداد مقالات9,995
تعداد مشاهده مقاله26,380,505
تعداد دریافت فایل اصل مقاله7,279,050
Forghani, Nima, Karimi, Zeinab, Mokhtari, Mokhtar, Shariati, Mehrdad, Masjedi, Fatemeh. (1401). Association of Oxidative Stress with Kidney Injury in a Hyperandrogenemic Female Rat Model. سامانه مدیریت نشریات علمی, 48(2), 187-197. doi: 10.30476/ijms.2022.93594.2497
Nima Forghani; Zeinab Karimi; Mokhtar Mokhtari; Mehrdad Shariati; Fatemeh Masjedi. "Association of Oxidative Stress with Kidney Injury in a Hyperandrogenemic Female Rat Model". سامانه مدیریت نشریات علمی, 48, 2, 1401, 187-197. doi: 10.30476/ijms.2022.93594.2497
Forghani, Nima, Karimi, Zeinab, Mokhtari, Mokhtar, Shariati, Mehrdad, Masjedi, Fatemeh. (1401). 'Association of Oxidative Stress with Kidney Injury in a Hyperandrogenemic Female Rat Model', سامانه مدیریت نشریات علمی, 48(2), pp. 187-197. doi: 10.30476/ijms.2022.93594.2497
Forghani, Nima, Karimi, Zeinab, Mokhtari, Mokhtar, Shariati, Mehrdad, Masjedi, Fatemeh. Association of Oxidative Stress with Kidney Injury in a Hyperandrogenemic Female Rat Model. سامانه مدیریت نشریات علمی, 1401; 48(2): 187-197. doi: 10.30476/ijms.2022.93594.2497

Association of Oxidative Stress with Kidney Injury in a Hyperandrogenemic Female Rat Model

Iranian Journal of Medical Sciences
مقاله 10، دوره 48، شماره 2، خرداد 2023، صفحه 187-197    اصل مقاله (561 K)
نوع مقاله: Original Article(s)
شناسه دیجیتال (DOI): 10.30476/ijms.2022.93594.2497
نویسندگان
Nima Forghani1؛ Zeinab Karimi* 2؛ Mokhtar Mokhtari1؛ Mehrdad Shariati1؛ Fatemeh Masjedi2
1Department of Biology, School of Sciences, Islamic Azad University, Kazerun Branch, Kazerun, Iran
2Shiraz Nephro-Urology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
چکیده
Background: Polycystic ovary syndrome (PCOS) is the most common reproductive dysfunction in premenopausal women. PCOS is associated with oxidative stress (OS), which is the main risk factor for renal diseases. This study aimed to investigate the mechanisms responsible for renal injury in a hyperandrogenemic female rat model. 
Methods: This study was conducted from December 2019 to September 2021 at Shiraz Nephro-Urology Research Centre, Shiraz University of Medical Sciences (Shiraz, Iran). Thirty female Sprague-Dawley rats were randomly divided into three groups (n=10), namely control, sham, and 
dehydroepiandrosterone (DHEA). Plasma total testosterone, plasma creatinine (Cr), and blood urea nitrogen (BUN) levels were measured. In addition, total oxidant status (TOS), total antioxidant capacity (TAC), oxidative stress index (OSI), and histopathological changes in the ovaries and kidneys were determined. Data were analyzed using the GraphPad Prism software, and P<0.05 was considered statistically significant.
Results: Plasma total testosterone levels increased by nine-fold in DHEA-treated rats compared to controls (P=0.0001). Administration of DHEA increased Cr and BUN levels and caused severe renal tubular cell injury. In addition, plasma and tissue (kidney and ovary) TAC levels decreased significantly, but TOS levels and OSI values were significantly increased (P=0.019). Significant damage to both glomerular and tubular parts of the kidney and ovarian follicular structure was observed in the DHEA group.
Conclusion: Hyperandrogenemia caused systemic abnormalities through OS-related mechanisms and damaged renal and ovarian tissues. DHEA treatment in rat models is recommended to study the mechanisms that mediate PCOS-associated renal injury.
کلیدواژه‌ها
Polycystic ovary syndrome؛ Oxidative stress؛ Dehydroepiandrosterone؛ Kidney disease
سایر فایل های مرتبط با مقاله
مراجع
  1. Azziz R, Carmina E, Chen Z, Dunaif A, Laven JS, Legro RS, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057. doi: 10.1038/nrdp.2016.57. PubMed PMID: 27510637.
  2. Chappell NR, Gibbons WE, Blesson CS. Pathology of hyperandrogenemia in the oocyte of polycystic ovary syndrome. Steroids. 2022;180:108989. doi: 10.1016/j.steroids.2022.108989. PubMed PMID: 35189133; PubMed Central PMCID: PMCPMC8920773.
  3. Rotterdam EA-SPcwg. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41-7. doi: 10.1093/humrep/deh098. PubMed PMID: 14688154.
  4. Bruni V, Capozzi A, Lello S. The Role of Genetics, Epigenetics and Lifestyle in Polycystic Ovary Syndrome Development: the State of the Art. Reprod Sci. 2022;29:668-79. doi: 10.1007/s43032-021-00515-4. PubMed PMID: 33709373.
  5. Dewailly D, Lujan ME, Carmina E, Cedars MI, Laven J, Norman RJ, et al. Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update. 2014;20:334-52. doi: 10.1093/humupd/dmt061. PubMed PMID: 24345633.
  6. Glintborg D. Endocrine and metabolic characteristics in polycystic ovary syndrome. Dan Med J. 2016;63. PubMed PMID: 27034186.
  7. McCartney CR, Campbell RE, Marshall JC, Moenter SM. The role of gonadotropin-releasing hormone neurons in polycystic ovary syndrome. J Neuroendocrinol. 2022;34:e13093. doi: 10.1111/jne.13093. PubMed PMID: 35083794; PubMed Central PMCID: PMCPMC9232905.
  8. Dewailly D, Robin G, Peigne M, Decanter C, Pigny P, Catteau-Jonard S. Interactions between androgens, FSH, anti-Mullerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary. Hum Reprod Update. 2016;22:709-24. doi: 10.1093/humupd/dmw027. PubMed PMID: 27566840.
  9. Zhang J, Tang L, Kong L, Wu T, Xu L, Pan X, et al. Ultrasound-guided transvaginal ovarian needle drilling for clomiphene-resistant polycystic ovarian syndrome in subfertile women. Cochrane Database Syst Rev. 2021;11:CD008583. doi: 10.1002/14651858.CD008583.pub3. PubMed PMID: 34735019; PubMed Central PMCID: PMCPMC8567741.
  10. Wang F, Yu B, Yang W, Liu J, Lu J, Xia X. Polycystic ovary syndrome resembling histopathological alterations in ovaries from prenatal androgenized female rats. J Ovarian Res. 2012;5:15. doi: 10.1186/1757-2215-5-15. PubMed PMID: 22607720; PubMed Central PMCID: PMCPMC3406938.
  11. Papalou O, Victor VM, Diamanti-Kandarakis E. Oxidative Stress in Polycystic Ovary Syndrome. Curr Pharm Des. 2016;22:2709-22. doi: 10.2174/1381612822666160216151852. PubMed PMID: 26881435.
  12. Masjedi F, Keshtgar S, Agah F, Karbalaei N. Association Between Sex Steroids and Oxidative Status with Vitamin D Levels in Follicular Fluid of Non-obese PCOS and Healthy Women. J Reprod Infertil. 2019;20:132-42. PubMed PMID: 31423416; PubMed Central PMCID: PMCPMC6670262.
  13. Masjedi F, Keshtgar S, Zal F, Talaei-Khozani T, Sameti S, Fallahi S, et al. Effects of vitamin D on steroidogenesis, reactive oxygen species production, and enzymatic antioxidant defense in human granulosa cells of normal and polycystic ovaries. J Steroid Biochem Mol Biol. 2020;197:105521. doi: 10.1016/j.jsbmb.2019.105521. PubMed PMID: 31705961.
  14. Caglar GS, Oztas E, Karadag D, Pabuccu R, Eren AA. The association of urinary albumin excretion and metabolic complications in polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2011;154:57-61. doi: 10.1016/j.ejogrb.2010.08.024. PubMed PMID: 20888116.
  15. Gozukara IO, Gozukara KH, Kucur SK, Karakilic EU, Keskin H, Akdeniz D, et al. Association of Glomerular Filtration Rate with Inflammation in Polycystic Ovary Syndrome. Int J Fertil Steril. 2015;9:176-82. doi: 10.22074/ijfs.2015.4238. PubMed PMID: 26246875; PubMed Central PMCID: PMCPMC4518485.
  16. Yanes LL, Romero DG, Moulana M, Lima R, Davis DD, Zhang H, et al. Cardiovascular-renal and metabolic characterization of a rat model of polycystic ovary syndrome. Gend Med. 2011;8:103-15. doi: 10.1016/j.genm.2010.11.013. PubMed PMID: 21536229; PubMed Central PMCID: PMCPMC3093922.
  17. Dalmasso C, Maranon R, Patil C, Bui E, Moulana M, Zhang H, et al. Cardiometabolic Effects of Chronic Hyperandrogenemia in a New Model of Postmenopausal Polycystic Ovary Syndrome. Endocrinology. 2016;157:2920-7. doi: 10.1210/en.2015-1617. PubMed PMID: 27145003; PubMed Central PMCID: PMCPMC4929551.
  18. Ratliff BB, Abdulmahdi W, Pawar R, Wolin MS. Oxidant Mechanisms in Renal Injury and Disease. Antioxid Redox Signal. 2016;25:119-46. doi: 10.1089/ars.2016.6665. PubMed PMID: 26906267; PubMed Central PMCID: PMCPMC4948213.
  19. Council NR, Studies DEL, Research ILA, Animals CUGCUL. Guide for the Care and Use of Laboratory Animals. Eighth Edition. Washington: National Academies Press; 2011.
  20. Charan J, Kantharia ND. How to calculate sample size in animal studies? J Pharmacol Pharmacother. 2013;4:303-6. doi: 10.4103/0976-500X.119726. PubMed PMID: 24250214; PubMed Central PMCID: PMCPMC3826013.
  21. Neisy A, Zal F, Seghatoleslam A, Alaee S. Amelioration by quercetin of insulin resistance and uterine GLUT4 and ERalpha gene expression in rats with polycystic ovary syndrome (PCOS). Reprod Fertil Dev. 2019;31:315-23. doi: 10.1071/RD18222. PubMed PMID: 30103849.
  22. Pinola P, Piltonen TT, Puurunen J, Vanky E, Sundstrom-Poromaa I, Stener-Victorin E, et al. Androgen Profile Through Life in Women With Polycystic Ovary Syndrome: A Nordic Multicenter Collaboration Study. J Clin Endocrinol Metab. 2015;100:3400-7. doi: 10.1210/jc.2015-2123. PubMed PMID: 26192874.
  23. Mesbah F, Moslem M, Vojdani Z, Mirkhani H. Does metformin improve in vitro maturation and ultrastructure of oocytes retrieved from estradiol valerate polycystic ovary syndrome-induced rats. J Ovarian Res. 2015;8:74. doi: 10.1186/s13048-015-0203-x. PubMed PMID: 26577050; PubMed Central PMCID: PMCPMC4650318.
  24. Walters KA, Allan CM, Handelsman DJ. Rodent models for human polycystic ovary syndrome. Biol Reprod. 2012;86:149. doi: 10.1095/biolreprod.111.097808. PubMed PMID: 22337333.
  25. Kim EJ, Jang M, Choi JH, Park KS, Cho IH. An Improved Dehydroepiandrosterone-Induced Rat Model of Polycystic Ovary Syndrome (PCOS): Post-pubertal Improve PCOS’s Features. Front Endocrinol (Lausanne). 2018;9:735. doi: 10.3389/fendo.2018.00735. PubMed PMID: 30564195; PubMed Central PMCID: PMCPMC6288467.
  26. Pakfetrat Z, Janfeshan S, Masjedi F, Rafiei M, Karimi Z. Involvement of oxidative stress and toll-like receptor-4 signaling pathways in gentamicin-induced nephrotoxicity in male Sprague Dawley rats. Drug Chem Toxicol. 2022;45:2568-75. doi: 10.1080/01480545.2021.1977024. PubMed PMID: 34538191.
  27. Gholampour F, Mohammadi Z, Karimi Z, Owji SM. Protective effect of genistein in a rat model of ischemic acute kidney injury. Gene. 2020;753:144789. doi: 10.1016/j.gene.2020.144789. PubMed PMID: 32442578.
  28. Duica F, Danila CA, Boboc AE, Antoniadis P, Condrat CE, Onciul S, et al. Impact of Increased Oxidative Stress on Cardiovascular Diseases in Women With Polycystic Ovary Syndrome. Front Endocrinol (Lausanne). 2021;12:614679. doi: 10.3389/fendo.2021.614679. PubMed PMID: 33679617; PubMed Central PMCID: PMCPMC7930620.
  29. Masjedi F, Gol A, Dabiri S, Javadi A. Investigating the Preventive Effect of Garlic on Blood Glucose Levels and Histopathology of Pancreas in Streptozotocin-induced Diabetic Rats. Physiology and Pharmacology. 2009;13:179-90.
  30. Kidney Disease: Improving Global Outcomes Diabetes Work G. KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int. 2020;98:S1-S115. doi: 10.1016/j.kint.2020.06.019. PubMed PMID: 32998798.
  31. Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil Steril. 2018;110:364-79. doi: 10.1016/j.fertnstert.2018.05.004. PubMed PMID: 30033227; PubMed Central PMCID: PMCPMC6939856.
  32. Patel AA, Bloomgarden ZT, Futterweit W. Premicroalbuminuria in women with polycystic ovary syndrome: a metabolic risk marker. Endocr Pract. 2008;14:193-200. doi: 10.4158/EP.14.2.193. PubMed PMID: 18308657.
  33. Eirin A, Lerman A, Lerman LO. The Emerging Role of Mitochondrial Targeting in Kidney Disease. Handb Exp Pharmacol. 2017;240:229-50. doi: 10.1007/164_2016_6. PubMed PMID: 27316914; PubMed Central PMCID: PMCPMC5164968.
  34. Song Y, Ye W, Ye H, Xie T, Shen W, Zhou L. Serum testosterone acts as a prognostic indicator in polycystic ovary syndrome-associated kidney injury. Physiol Rep. 2019;7:e14219. doi: 10.14814/phy2.14219. PubMed PMID: 31448581; PubMed Central PMCID: PMCPMC6709419.
  35. Zhang J, Bao Y, Zhou X, Zheng L. Polycystic ovary syndrome and mitochondrial dysfunction. Reprod Biol Endocrinol. 2019;17:67. doi: 10.1186/s12958-019-0509-4. PubMed PMID: 31420039; PubMed Central PMCID: PMCPMC6698037.
  36. Zuo T, Zhu M, Xu W. Roles of Oxidative Stress in Polycystic Ovary Syndrome and Cancers. Oxid Med Cell Longev. 2016;2016:8589318. doi: 10.1155/2016/8589318. PubMed PMID: 26770659; PubMed Central PMCID: PMCPMC4684888.
  37. Ahmadi M, Rostamzadeh A, Fathi F, Mohammadi M, Rezaie MJ. The effect of Melatonin on histological changes of ovary in induced polycystic ovary syndrome model in mice. Middle East Fertility Society Journal. 2017;22:255-9. doi: 10.1016/j.mefs.2017.03.009.
  38. Forghani N, Karimi Z, Mokhtar M, Shariati M, Masjedi F. Functional and histopathological kidney injury in hyperandrogenic female rats-a polycystic ovary animal model. Medical Journal of Tabriz University of Medical Sciences. 2022;44:26-35. doi: 10.34172/mj.2022.011.
  39. Rezvanfar MA, Shojaei Saadi HA, Gooshe M, Abdolghaffari AH, Baeeri M, Abdollahi M. Ovarian aging-like phenotype in the hyperandrogenism-induced murine model of polycystic ovary. Oxid Med Cell Longev. 2014;2014:948951. doi: 10.1155/2014/948951. PubMed PMID: 24693338; PubMed Central PMCID: PMCPMC3945218.
  40. Diamanti-Kandarakis E. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. Expert Rev Mol Med. 2008;10:e3. doi: 10.1017/S1462399408000598. PubMed PMID: 18230193.
آمار
تعداد مشاهده مقاله: 964
تعداد دریافت فایل اصل مقاله: 551


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب